Applications are now available for the New York Fund for Innovation in Research and Scientific Talent, a $15 million medical school capital funding program to encourage recruitment and retention of exceptional life science researchers. The program hopes to target scientists focused on translational research by supporting the establishment or upgrading of their laboratories.
“As New York rapidly emerges as a world-class hub for life sciences research and commercialization, it is vital that we continue to attract world-class talent to lead the way,” said Howard Zemsky, president, CEO and commissioner of Empire State Development. “NY FIRST will help ensure that New York’s medical institutions remain state-of-the-art, competitive spaces where top-notch researchers can do this groundbreaking work.”
NY FIRST makes a maximum grant of $1 million to eligible institutional applicants to modernize, renovate and upgrade laboratory facilities to attract world-class scientists to medical schools in New York State. Program grant awards will be made through an annual competitive grant solicitation, conducted for up to three years or until funds are fully committed. Grantees are required to provide $2 in matching funds for every $1 of NY FIRST program assistance.
The scientific talent recruited or retained to head these new or upgraded labs must demonstrate a history of translational research and actively pursuing research on an innovative solution for an unmet clinical need. The researcher is required to demonstrate a clear path to commercialization with the potential for significant life sciences economic development benefits in New York State, such as increased patent applications and patentable discoveries; increased recruitment/retention of medical school faculty focused on translational research; or an increase in the number of life sciences jobs created or retained.
The NY FIRST application may be downloaded here. This round of applications is due Friday, June 15.